Compare IMMR & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMMR | ORGO |
|---|---|---|
| Founded | 1993 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 215.8M | 181.4M |
| IPO Year | 1999 | 2016 |
| Metric | IMMR | ORGO |
|---|---|---|
| Price | $7.31 | $1.40 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 294.4K | ★ 534.3K |
| Earning Date | 09-14-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.15% | N/A |
| EPS Growth | N/A | ★ 1600.00 |
| EPS | ★ 0.17 | N/A |
| Revenue | $35,013,000.00 | ★ $564,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $37.55 |
| P/E Ratio | $42.76 | ★ N/A |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $5.25 | $1.34 |
| 52 Week High | $8.05 | $7.08 |
| Indicator | IMMR | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 46.04 | 31.90 |
| Support Level | $6.30 | $1.34 |
| Resistance Level | $7.65 | $2.55 |
| Average True Range (ATR) | 0.16 | 0.06 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 38.74 | 17.65 |
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.